|
|
Blood, 1 May 2005, Vol. 105, No. 9, pp. 3588-3595.
Prepublished online as a Blood First Edition Paper on December 16, 2004; DOI 10.1182/blood-2004-08-3251.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Reversal of long-term sepsis-induced immunosuppression by dendritic cells
Claudia F. Benjamim,
Steven K. Lundy,
Nicholas W. Lukacs,
Cory M. Hogaboam, and
Steven L. Kunkel
From the Department of Pathology, University of Michigan, Medical School, Ann Arbor, MI.
Severe sepsis leads to long-term systemic and local immunosuppression, which is the cause of a number of complications, including pulmonary infection. A therapeutic strategy that reverses this immunosuppression is required, given the ongoing high mortality rate of patients who have survived a severe sepsis. The present study demonstrates that experimental severe sepsis renders the lung susceptible to a normally innocuous Aspergillus fumigatus fungus challenge, due to a dominant lung type 2 cytokine profile. Dendritic cells (DCs) obtained from the lungs of mice subjected to cecal ligation and puncture (CLP) model were skewed toward type 2 cytokine profile, which occurred with exaggerated expression of Toll-like receptor 2 (TLR2). The intrapulmonary transfer of bone marrow–derived DCs (BMDCs) in postseptic mice prevented fatal Aspergillus infection. This therapy reduced the overall inflammatory response and fungal growth in the lung, and promoted the balance of proinflammatory and suppressive cytokines in the lung. Thus, intrapulmonary DC supplementation appears to restore the pulmonary host response in the postseptic lung in our animal model. These data strongly suggest that lung DCs are profoundly affected as a consequence of the systemic impact of severe sepsis, and the identification of mechanisms that restore their function may serve as a key strategy to reverse sepsis-induced immunosuppression.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Plitas, B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo
Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis
J. Exp. Med.,
June 9, 2008;
205(6):
1277 - 1283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wen, M. A. Schaller, Y. Dou, C. M. Hogaboam, and S. L. Kunkel
Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes
J. Leukoc. Biol.,
March 1, 2008;
83(3):
439 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wen, Y. Dou, C. M. Hogaboam, and S. L. Kunkel
Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response
Blood,
February 15, 2008;
111(4):
1797 - 1804.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wen, C. M. Hogaboam, J. Gauldie, and S. L. Kunkel
Severe Sepsis Exacerbates Cell-Mediated Immunity in the Lung Due to an Altered Dendritic Cell Cytokine Profile
Am. J. Pathol.,
June 1, 2006;
168(6):
1940 - 1950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Flohe, H. Agrawal, D. Schmitz, M. Gertz, S. Flohe, and F. U. Schade
Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response
J. Leukoc. Biol.,
March 1, 2006;
79(3):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Knapp, C. W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, N. Tshimbalanga, S. Akira, and T. van der Poll
Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Am. J. Respir. Crit. Care Med.,
January 1, 2006;
173(1):
122 - 129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J. Carpenter and C. M. Hogaboam
Immunosuppressive Effects of CCL17 on Pulmonary Antifungal Responses during Pulmonary Invasive Aspergillosis
Infect. Immun.,
November 1, 2005;
73(11):
7198 - 7207.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
